Meroterpenoid enantiomers from Ganoderma sinensis.

Area of Science:

• Natural Product Chemistry
• Medicinal Chemistry
• Pharmacognosy

Background:

• Ganoderma species are a rich source of bioactive secondary metabolites.
• Meroterpenoids, complex compounds derived from terpenoid and aromatic precursors, are frequently found in Ganoderma.
• Understanding the chemical diversity and biological activities of Ganoderma metabolites is crucial for potential therapeutic applications.

Purpose of the Study:

• To isolate and elucidate the structures of new meroterpenoids from Ganoderma sinensis.
• To investigate the potential of these isolated compounds to inhibit fibronectin generation.
• To contribute to the chemical knowledge of Ganoderma species.

Main Methods:

• Isolation of compounds from fruiting bodies of Ganoderma sinensis using chromatographic techniques.
• Structure elucidation of new meroterpenoids (Zizhines A-F) employing spectroscopic methods (NMR, MS) and computational analyses.
• In vitro bioactivity assay using TGF-β1-induced rat kidney tubular epithelial cells to evaluate inhibition of fibronectin generation.

Main Results:

• Six new meroterpenoid enantiomers, Zizhines A-F (1-6), and one known meroterpenoid (7) were successfully isolated.
• The structures and absolute configurations of the novel compounds were determined.
• None of the tested compounds (1-6) demonstrated significant inhibition of fibronectin generation in the employed cell model.

Conclusions:

• The study successfully expanded the known chemical repertoire of Ganoderma meroterpenoids with the identification of Zizhines A-F.
• Despite the lack of observed bioactivity in this specific assay, the findings highlight the ongoing discovery of novel chemical entities from natural sources.
• Further investigations into the biological activities of these and related Ganoderma compounds may reveal different therapeutic potentials.